NCR1 and neuroblastoma: High expression of NCR1/NKp46 was associated with better survival in NB patients regardless of THBD/CD141 expression (log-rank P values: 2.8 × 10−13 and 0.026, respectively, for overall survival, and log-rank P value: 1.68 × 10−8 for event-free survival) (Fig. 5f, 5g and Supplementary Fig. 10b).